Fuchs corneal dystrophy

Expert Review of Ophthalmology

Volumn 5, Issue 2, 2010, Pages 147-159

  Eghrari, Allen O ^a   Gottsch, John D ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

Descemet membrane; DSEK; Endothelium; Fuchs corneal dystrophy; Guttae

Indexed keywords

AQUAPORIN 1; AQUAPORIN 3; AQUAPORIN 4; CATHEPSIN; CLUSTERIN; COLLAGEN TYPE 8; MURO 128; PROTEIN BAX; PROTEIN BCL 2; PROTEIN P27; SODIUM CHLORIDE; SURVIVIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR 8; UNCLASSIFIED DRUG;

BLURRED VISION; CELL DENSITY; CLINICAL FEATURE; CLOSED ANGLE GLAUCOMA; CONFOCAL MICROSCOPY; CONGENITAL CORNEA DYSTROPHY; CORNEA EDEMA; CORNEA TRANSPLANTATION; DESCEMET MEMBRANE; DESCEMET STRIPPING ENDOTHELIAL KERATOPLASTY; DISEASE ASSOCIATION; DISEASE COURSE; DISEASE DURATION; ENDOTHELIUM CELL; GENE MUTATION; HERITABILITY; HUMAN; HYPERMETROPIA; MINIMALLY INVASIVE SURGERY; OPTICAL COHERENCE TOMOGRAPHY; PATHOGENESIS; PENETRATING KERATOPLASTY; PREVALENCE; REFRACTIVE SURGERY; REVIEW; RISK FACTOR; TREATMENT OUTCOME; ULTRAVIOLET RADIATION;

EID: 77951644165     PISSN: 17469899     EISSN: 17469902     Source Type: Journal    
DOI: 10.1586/eop.10.8     Document Type: Review

References (147)

1. Fuchs E. Dystrophia epithelialis corneae. Graefes. Arch. Clin. Exp. Ophthalmol. 478-508 (1910).
2. Friedenwald H, Friedenwald JS. Epithelial dystrophy of the cornea. Br. J. Ophthalmol 9, 14-20 (1925).
3. Knapp A. Dystrophia epithelialis corneae (Fuchs), with the report of a case. Trans. Am. Ophthalmol. Soc. 12, 745-747 (1911).
4. Langdon HM. A case of dystrophy of the cornea which disappeared on the adminstration of fats. Am. J. Ophthalmol 11, 386 (1928).
5. Report of the Proceedings of the Section on Ophthalmology of the New York Academy of Medicine, October 21, 1912. Arch. Ophthalmol. 42, 182 (1913).
6. Uribe y Troncoso M. Annal. Ophthalmol XXI, 369 (1912).
7. Clegg JG. Remarks on dystrophies of the cornea and glaucoma, with especial reference to a familial variety of the former. Trans. Opthal. Soc. UK 35, 245-253 (1915).
8. Vogt A. Weitere Ergebnisse der Spaltlampenmikroskopie des vordern Bulbusabschnittes. Arch. Ophthalmol 63-113 (1921).
9. Graves B. Report to the Lang Clinical Research Committee, Royal London Ophthalmic Hospital: a bilateral chronic affection of the endothelial face of the cornea of elderly persons with an account of the technical and clinical principles of its slit-lamp observation. Br. J. Ophthalmol. 8, 502-544 (1924).
10. Webster D. Report of the Proceedings of the Section on Ophthalmology of the New York Academy of Medicine. Arch. Ophthalmol. 55, 165 (1926).
11. Gifford S. Epithelial dystrophy of the cornea and its relation to endothelial dystrophy. Am. J. Ophthalmol. 9, 81-85 (1926).
12. Lietman T, Lee J, Costanza S. Those excrescences on Descemet s membrane. Br. J. Ophthalmol. 87, 515-516 (2003).
13. Goar EL. Dystrophy of the corneal endothelium (cornea guttata), with report of a histologic examination. Trans. Am. Ophthalmol. Soc. 31, 48-59 (1933).
14. Lorenzetti DW, Uotila MH, Parikh N, Kaufman HE. Central cornea guttata. Incidence in the general population. Am. J. Ophthalmol. 64, 1155-1158 (1967).
15. Zoega GM, Fujisawa A, Sasaki H, et al. Prevalence and risk factors for cornea guttata in the Reykjavik Eye Study. Ophthalmology 113, 565-569 (2006).
16. Nagaki Y, Hayasaka S, Kitagawa K, Yamamoto S. Primary cornea guttata in Japanese patients with cataract: specular microscopic observations. Jpn J. Ophthalmol. 40, 520-525 (1996).
17. Kitagawa K, Kojima M, Sasaki H, et al. Prevalence of primary cornea guttata and morphology of corneal endothelium in aging Japanese and Singaporean subjects. Ophthalmic. Res. 34, 135-138 (2002).
18. Whitham LB. Clinical contribution to the etiology of dystrophia epithelialis corneae. Trans. Am. Ophthalmol. Soc. 22, 290-299 (1924).
19. Matsuda M, Yee RW, Edelhauser HF. Comparison of the corneal endothelium in an American and a Japanese population. Arch. Ophthalmol. 103, 68-70 (1985).
20. Pitts JF, Jay JL. The association of Fuchs's corneal endothelial dystrophy with axial hypermetropia, shallow anterior chamber, and angle closure glaucoma. Br. J. Ophthalmol. 74, 601-604 (1990).
21. Loewenstein A, Geyer O, Hourvitz D, Lazar M. The association of Fuch's corneal endothelial dystrophy with angle closure glaucoma. Br. J. Ophthalmol. 75, 510 (1991).
22. Roberts CW, Steinert RF, Thomas JV, Boruchoff SA. Endothelial guttata and facility of aqueous outfow. Cornea 3, 5-9 (1984).
23. Rao GP, Kaye SB, Gius-Fernandez A Central Corneal Endothelial Guttae and Age-related Macular Degeneration: Is There An Association? Indian J. Ophthalmol. 46, 145-147 (1998).
24. Cremona FA, Ghosheh FR, Rapuano CJ, et al. Keratoconus associated with other corneal dystrophies. Cornea 28, 127-135 (2009).
25. Olsen T. Is there an association between Fuchs' endothelial dystrophy and cardiovascular disease? Graefes. Arch. Clin. Exp. Ophthalmol. 221, 239-240 (1984).
26. Albin RL. Fuch's corneal dystrophy in a patient with mitochondrial DNA mutations. J. Med. Genet. 35, 258-259 (1998).
27. Sundin OH, Jun AS, Broman KW, et al. Linkage of late-onset Fuchs corneal dystrophy to a novel locus at 13pTel-13q12.13. Invest. Ophthalmol. Vis. Sci. 47, 140-145 (2006).
28. Meadows DN, Eghrari AO, Riazuddin SA, et al. Progression of Fuchs corneal dystrophy in a family linked to the FCD1 locus. Invest. Ophthalmol. Vis. Sci. 50(12), 5662-5666 (2009).
29. Klyce SD. Transport of Na, Cl, and water by the rabbit corneal epithelium at resting potential. Am. J. Physiol. 228, 1446-1452 (1975).
30. Maurice DM. The location of the fuid pump in the cornea. J. Physiol. 221, 43-54 (1972).
31. Waring GO III, Rodrigues MM, Laibson PR. Corneal dystrophies. II. Endothelial dystrophies. Surv. Ophthalmol. 23, 147-168 (1978).
32. Dastjerdi MH, Sugar A. Corneal decompensation after laser in situ keratomileusis in Fuchs' endothelial dystrophy. Cornea 22, 379-381 (2003).
33. Olson LE, Marshall J, Rice NS, Andrews R. Effects of ultrasound on the corneal endothelium: II. The endothelial repair process. Br. J. Ophthalmol. 62, 145-154 (1978). (Pubitemid 8314468)
34. Kuwabara T, Quevedo AR, Cogan DG. An experimental study of dichloroethane poisoning. Arch. Ophthalmol. 79, 321-330 (1968).
35. Waring GO, Font RL, Rodrigues MM, Mulberger RD. Alterations of Descemet's membrane in interstitial keratitis. Am. J. Ophthalmol. 81, 773-785 (1976).
36. Renard G, Dhermy P, Pouliquen Y. Secondary dystrophies of corneal endothelium and Descemet's membrane: histological and ultrastructural study (author's transl). J. Fr. Ophtalmol. 4, 721-739 (1981).
37. Roth SI, Stock EL, Jutabha R. Endothelial viral inclusions in Fuchs' corneal dystrophy. Hum. Pathol. 18, 338-341 (1987).
38. Cross HE, Maumenee AE, Cantolino SJ. Inheritance of Fuchs' endothelial dystrophy. Arch. Ophthalmol. 85, 268-272 (1971).
39. Krachmer JH, Purcell JJ Jr, Young CW, Bucher KD. Corneal endothelial dystrophy. A study of 64 families. Arch. Ophthalmol. 96, 2036-2039 (1978).
40. Rosenblum P, Stark WJ, Maumenee IH, Hirst LW, Maumenee AE. Hereditary Fuchs' dystrophy. Am. J. Ophthalmol. 90, 455-462 (1980).
41. Magovern M, Beauchamp GR, McTigue J W, Fine BS, Baumiller RC. Inheritance of Fuchs' combined dystrophy. Ophthalmology 86, 1897-1923 (1979).
42. Biswas S, Munier FL, Yardley J, et al. Missense mutations in COL8A2, the gene encoding the a2 chain of type VIII collagen, cause two forms of corneal endothelial dystrophy. Hum. Mol. Genet. 10, 2415-2423 (2001).
43. Gottsch JD, Sundin OH, Liu SH, et al. Inheritance of a novel COL8A2 mutation defnes a distinct early-onset subtype of fuchs corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 46, 1934-1939 (2005).
44. Liskova P, Prescott Q, Bhattacharya SS, Tuft SJ. British family with early-onset Fuchs' endothelial corneal dystrophy associated with p.L450W mutation in the COL8A2 gene. Br. J. Ophthalmol. 91, 1717-1718 (2007).
45. Mok JW, Kim HS, Joo CK. Q455V mutation in COL8A2 is associated with Fuchs' corneal dystrophy in Korean patients. Eye (Lond.) 23, 895-903 (2009).
46. Aldave AJ, Rayner SA, Salem AK, et al. No pathogenic mutations identifed in the COL8A1 and COL8A2 genes in familial Fuchs corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 47, 3787-3790 (2006).
47. Johnson DH, Bourne WM, Campbell RJ. The ultrastructure of Descemet's membrane. I. Changes with age in normal corneas. Arch. Ophthalmol. 100, 1942-1947 (1982).
48. Zhang C, Bell WR, Sundin OH, et al. Immunohistochemistry and electron microscopy of early-onset fuchs corneal dystrophy in three cases with the same L450W COL8A2 mutation. Trans. Am. Ophthalmol. Soc. 104, 85-97 (2006).
49. Gottsch JD, Zhang C, Sundin OH, Bell WR, Stark WJ, Green WR. Fuchs corneal dystrophy: aberrant collagen distribution in an L450W mutant of the COL8A2 gene. Invest. Ophthalmol. Vis. Sci. 46, 4504-4511 (2005).
50. Sundin OH, Broman KW, Chang HH, Vito EC, Stark WJ, Gottsch JD. A common locus for late-onset Fuchs corneal dystrophy maps to 18q21.2-q21.32. Invest. Ophthalmol. Vis. Sci. 47, 3919-3926 (2006).
51. Riazuddin SA, Eghrari AO, Al-Saif A, et al. Linkage of a mild late-onset phenotype of Fuchs corneal dystrophy to a novel locus at 5q33.1-q35.2. Invest. Ophthalmol. Vis. Sci. 50(12), 5667-5671 (2009).
52. Riazuddin SA, Zaghloul NA, Al-Saif A, et al. Missense mutations in TCF8 cause late-onset Fuchs corneal dystrophy and interact with FCD4 on chromosome 9p. Am. J. Hum. Genet. 86(1), 45-53 (2010).
53. Krafchak CM, Pawar H, Moroi SE, et al. Mutations in TCF8 cause posterior polymorphous corneal dystrophy and ectopic expression of COL4A3 by corneal endothelial cells. Am. J. Hum. Genet. 77, 694-708 (2005).
54. Mehta JS, Vithana EN, Tan DT, et al. Analysis of the posterior polymorphous corneal dystrophy 3 gene, TCF8, in late-onset Fuchs endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 49, 184-188 (2008).
55. Afshari NA, Li YJ, Pericak-Vance MA, Gregory S, Klintworth GK. Genome-wide linkage scan in Fuchs endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 50, 1093-1097 (2009).
56. Jiao X, Sultana A, Garg P, et al. Autosomal recessive corneal endothelial dystrophy (CHED2) is associated with mutations in SLC4A11. J. Med. Genet. 44, 64-68 (2007). (Pubitemid 46142841)
57. Sultana A, Garg P, Ramamurthy B, Vemuganti GK, Kannabiran C. Mutational spectrum of the SLC4A11 gene in autosomal recessive congenital hereditary endothelial dystrophy. Mol. Vis. 13, 1327-1332 (2007).
58. Aldahmesh MA, Khan AO, Meyer BF, Alkuraya FS. Mutational spectrum of SLC4A11 in autosomal recessive CHED in Saudi Arabia. Invest. Ophthalmol. Vis. Sci. 50, 4142-4145 (2009).
59. Gottsch JD, Bowers AL, Margulies EH, et al. Serial analysis of gene expression in the corneal endothelium of Fuchs' dystrophy. Invest. Ophthalmol. Vis. Sci. 44, 594-599 (2003).
60. Vithana EN, Morgan PE, Ramprasad V, et al. SLC4A11 mutations in Fuchs endothelial corneal dystrophy. Hum. Mol. Genet. 17, 656-666 (2008).
61. Borderie VM, Baudrimont M, Vallee A, Ereau TL, Gray F, Laroche L. Corneal endothelial cell apoptosis in patients with Fuchs' dystrophy. Invest. Ophthalmol. Vis. Sci. 41, 2501-2505 (2000).
62. Bourne WM, Johnson DH, Campbell RJ. The ultrastructure of Descemet's membrane. III. Fuchs' dystrophy. Arch. Ophthalmol. 100, 1952-1955 (1982).
63. Ko MK, Park WK, Lee JH, Chi JG. A histomorphometric study of corneal endothelial cells in normal human fetuses. Exp. Eye Res. 72, 403-409 (2001).
64. Wilson RS, Roper-Hall MJ. Effect of age on the endothelial cell count in the normal eye. Br. J. Ophthalmol. 66, 513-515 (1982).
65. Williams KK, Noe RL, Grossniklaus HE, Drews-Botsch C, Edelhauser HF. Correlation of histologic corneal endothelial cell counts with specular microscopic cell density. Arch. Ophthalmol. 110, 1146-1149 (1992).
66. Bahn CF, Glassman RM, MacCallum DK, et al. Postnatal development of corneal endothelium. Invest. Ophthalmol. Vis. Sci. 27, 44-51 (1986).
67. Mustonen RK, McDonald MB, Srivannaboon S, Tan AL, Doubrava MW, Kim CK. In vivo confocal microscopy of Fuchs' endothelial dystrophy. Cornea 17, 493-503 (1998).
68. Laing RA, Sanstrom MM, Berrospi AR, Leibowitz HM. Changes in the corneal endothelium as a function of age. Exp. Eye Res. 22, 587-594 (1976).
69. Jurkunas U V, Rawe I, Bitar MS, et al. Decreased expression of peroxiredoxins in Fuchs' endothelial dystrophy. Invest. Ophthalmol. Vis. Sci. 49, 2956-2963 (2008).
70. Szentmary N, Szende B, Suveges I. Epithelial cell, keratocyte, and endothelial cell apoptosis in Fuchs' dystrophy and in pseudophakic bullous keratopathy. Eur. J. Ophthalmol. 15, 17-22 (2005).
71. Li QJ, Ashraf MF, Shen DF, et al. The role of apoptosis in the pathogenesis of Fuchs endothelial dystrophy of the cornea. Arch. Ophthalmol. 119, 1597-1604 (2001).
72. Szentmary N, Szende B, Suveges I. P53, CD95, cathepsin and survivin pathways in Fuchs' dystrophy and pseudophakic bullous keratopathy corneas. Histol. Histopathol. 23, 911-916 (2008).
73. Jurkunas U V, Bitar M, Rawe I. Colocalization of increased transforming growth factor-b-induced protein (TGFbIp) and clusterin in Fuchs endothelial corneal dystrophy. Invest. Ophthalmol. Vis. Sci. 50, 1129-1136 (2009).
74. Kenney MC, Atilano SR, Zorapapel N, Holguin B, Gaster RN, Ljubimov AV. Altered expression of aquaporins in bullous keratopathy and Fuchs' dystrophy corneas. J. Histochem. Cytochem. 52, 1341-1350 (2004).
75. Read SA, Collins MJ. Diurnal variation of corneal shape and thickness. Optom. Vis. Sci. 86, 170-180 (2009).
76. Giuffre G, Di Rosa L, Fiorino F, Bubella DM, Lodato G. Variations in central corneal thickness during the menstrual cycle in women. Cornea 26, 144-146 (2007).
77. Laing RA, Leibowitz HM, Oak SS, Chang R, Berrospi AR, Theodore J. Endothelial mosaic in Fuchs' dystrophy. A qualitative evaluation with the specular microscope. Arch. Ophthalmol. 99, 80-83 (1981).
78. Dong WL, Zou LH, Pan ZQ, Wang L. Morphologic characteristics of cornea in Fuchs endothelial dystrophy observed by confocal microscopy. Zhonghua Yan Ke Za Zhi 40, 465-470 (2004).
79. Chiou AG, Kaufman SC, Beuerman RW, Ohta T, Soliman H, Kaufman HE. Confocal microscopy in cornea guttata and Fuchs' endothelial dystrophy. Br. J. Ophthalmol. 83, 185-189 (1999).
80. Rokita-Wala I, Mrukwa-Kominek E, Gierek-Ciaciura S. Changes in corneal structure observed with confocal microscopy during Fuchs endothelial dystrophy. Klin. Oczna. 102, 339-344 (2000).
81. Hara M, Morishige N, Chikama T, Nishida T. Comparison of confocal biomicroscopy and noncontact specular microscopy for evaluation of the corneal endothelium. Cornea 22, 512-515 (2003).
82. Fayol N, Labbe A, Dupont-Monod S, Dupas B, Baudouin C. Contribution of confocal microscopy and anterior chamber OCT to the study of corneal endothelial pathologies. J. Fr. Ophtalmol. 30, 348-356 (2007).
83. Kaluzny BJ, Szkulmowska A, Szkulmowski M, Bajraszewski T, Kowalczyk A, Wojtkowski M. Fuchs' endothelial dystrophy in 830-nm spectral domain optical coherence tomography. Ophthalmic. Surg. Lasers Imag. 40, 198-200 (2009).
84. Gottsch JD, Sundin OH, Rencs EV, et al. Analysis and documentation of progression of Fuchs corneal dystrophy with retroillumination photography. Cornea 25, 485-489 (2006).
85. Leahey BD. Penetrating keratoplasty; observations based on a series of 148 cases with special emphasis on techniques of graft fxation. Trans. Am. Ophthalmol. Soc. 55, 575-636 (1957).
86. Stocker F W. Successful corneal graft in a case of endothelial and epithelial dystrophy. Am. J. Ophthalmol. 35, 349-352 (1952).
87. Seitzman GD, Gottsch JD, Stark WJ. Cataract surgery in patients with Fuchs' corneal dystrophy: expanding recommendations for cataract surgery without simultaneous keratoplasty. Ophthalmology 112, 441-446 (2005).
88. Pineros OE, Cohen EJ, Rapuano CJ, Laibson PR. Triple vs nonsimultaneous procedures in Fuchs' dystrophy and cataract. Arch. Ophthalmol. 114, 525-528 (1996).
89. Pineros O, Cohen EJ, Rapuano CJ, Laibson PR. Long-term results after penetrating keratoplasty for Fuchs' endothelial dystrophy. Arch. Ophthalmol. 114, 15-18 (1996).
90. Tillett CW Posterior lamellar keratoplasty Am. J. Ophthalmol. 41, 530-533 (1956).
91. Melles GR, Eggink FA, Lander F, et al. A surgical technique for posterior lamellar keratoplasty. Cornea 17, 618-626 (1998).
92. Heidemann DG, Dunn SP, Chow CY. Comparison of deep lamellar endothelial keratoplasty and penetrating keratoplasty in patients with Fuchs endothelial dystrophy. Cornea 27, 161-167 (2008).
93. Terry MA, Shamie N, Chen ES, et al. Endothelial keratoplasty for Fuchs' dystrophy with cataract: complications and clinical results with the new triple procedure. Ophthalmology 116, 631-639 (2009).
94. Ponchel C, Arne JL, Malecaze F, Fournie P. Survey of complications in Descemet stripping automated endothelial keratoplasty in 32 eyes. J. Fr. Ophtalmol 32(4), 257-262 (2009).
95. Lee JS, Desai NR, Schmidt GW, et al Secondary angle closure caused by air migrating behind the pupil in descemet stripping endothelial keratoplasty. Cornea 28, 652-656 (2009).
96. Vajaranant TS, Price MO, Price FW, Gao W, Wilensky JT, Edward DP. Visual acuity and intraocular pressure after Descemet s stripping endothelial keratoplasty in eyes with and without preexisting glaucoma. Ophthalmology 116, 1644-1650 (2009).
97. Lee WB, Jacobs DS, Musch DC, Kaufman SC, Reinhart WJ, Shtein RM. Descemets stripping endothelial keratoplasty: safety and outcomes: a report by the American Academy of Ophthalmology. Ophthalmology 116, 1818-1830 (2009).
98. Melles GR, Ong TS, Ververs B, van der Wees J. Descemet membrane endothelial keratoplasty (DMEK). Cornea 25, 987-990 (2006).
99. Dapena I, Ham L, Lie J, Van Der Wees J, Melles GR. Descemet membrane endothelial keratoplasty (DMEK): two-year results. Arch. Soc. Esp. Oftalmol 84, 237-243 (2009).
100. Ham L, Dapena I, van Luijk C, van der Wees J, Melles GR. Descemet membrane endothelial keratoplasty (DMEK) for Fuchs endothelial dystrophy: review of the frst 50 consecutive cases. Eye (Lond.) 23(10), 1990-1998 (2009).
101. Dapena I, Ham L, van Luijk C, van der Wees J, Melles GR. Back-up procedure for graft failure in Descemet membrane endothelial keratoplasty (DMEK). Br. J. Ophthalmol. 94(2), 241-244 (2010).
102. Moshirfar M, Feiz V, Feilmeier MR, Kang PC. Laser in situ keratomileusis in patients with corneal guttata and family history of Fuchs' endothelial dystrophy. J. Cataract Refract. Surg. 31, 2281-2286 (2005).
103. Lai JY, Chen KH, Hsiue GH. Tissue-engineered human corneal endothelial cell sheet transplantation in a rabbit model using functional biomaterials. Transplantation 84, 1222-1232 (2007).
104. Mimura T, Yamagami S, Yokoo S, et al. Cultured human corneal endothelial cell transplantation with a collagen sheet in a rabbit model. Invest. Ophthalmol. Vis. Sci. 45, 2992-2997 (2004).
105. Hitani K, Yokoo S, Honda N, Usui T, Yamagami S, Amano S. Transplantation of a sheet of human corneal endothelial cell in a rabbit model. Mol. Vis. 14, 1-9 (2008).
106. Yoeruek E, Saygili O, Spitzer MS, Tatar O, Bartz-Schmidt KU, Szurman P. Human anterior lens capsule as carrier matrix for cultivated human corneal endothelial cells. Cornea 28, 416-420 (2009).
107. Patel SV, Bachman LA, Hann CR, Bahler CK, Fautsch MP. Human corneal endothelial cell transplantation in a human ex vivo model. Invest. Ophthalmol. Vis. Sci. 50, 2123-2131 (2009).
108. Ghosheh FR, Cremona F, Ayres BD, et al. Indications for penetrating keratoplasty and associated procedures, 2001-2005. Eye Contact Lens 34, 211-214 (2008).
109. Cosar CB, Sridhar MS, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures, 1996-2000. Cornea 21, 148-151 (2002).
110. Lois N, Kowal VO, Cohen EJ, et al. Indications for penetrating keratoplasty and associated procedures, 1989-1995. Cornea 16, 623-629 (1997).
111. Brady SE, Rapuano CJ, Arentsen JJ, Cohen EJ, Laibson PR. Clinical indications for and procedures associated with penetrating keratoplasty, 1983-1988. Am. J. Ophthalmol. 108, 118-122 (1989).
112. Kang PC, Klintworth GK, Kim T, et al. Trends in the indications for penetrating keratoplasty, 1980-2001. Cornea 24, 801-803 (2005).
113. Dobbins KR, Price FW Jr, Whitson WE. Trends in the indications for penetrating keratoplasty in the midwestern United States. Cornea 19, 813-816 (2000).
114. Lindquist TD, McGlothan JS, Rotkis WM, Chandler JW. Indications for penetrating keratoplasty: 1980-1988. Cornea 10, 210-216 (1991).
115. Mamalis N, Anderson CW, Kreisler KR, Lundergan MK, Olson RJ. Changing trends in the indications for penetrating keratoplasty. Arch. Ophthalmol. 110, 1409-1411 (1992).
116. Flowers CW, Chanq KY, McLeod SD, et al. Changing indications for penetrating keratoplasty, 1989-1993. Cornea 14, 583-588 (1995).
117. Mohamadi P, McDonnell JM, Irvine JA, McDonnell PJ, Rao N, Smith RE. Changing indications for penetrating keratoplasty, 1984-1988. Am. J. Ophthalmol. 107, 550-552 (1989).
118. Godeiro KD, Coutinho AB, Pereira PR, Fernandes BF, Cassie A, Burnier MN Jr. Histopathological diagnosis of corneal button specimens: an epidemiological study. Ophthalmic. Epidemiol. 14, 70-75 (2007).
119. Dorrepaal SJ, Cao KY, Slomovic AR. Indications for penetrating keratoplasty in a tertiary referral centre in Canada, 1996-2004. Can. J. Ophthalmol. 42, 244-250 (2007).
120. Liu E, Slomovic AR. Indications for penetrating keratoplasty in Canada, 1986-1995. Cornea 16, 414-419 (1997).
121. Maeno A, Naor J, Lee HM, Hunter WS, Rootman DS. Three decades of corneal transplantation: indications and patient characteristics. Cornea 19, 7-11 (2000).
122. Haamann P, Jensen OM, Schmidt P. Changing indications for penetrating keratoplasty. Acta Ophthalmol. (Copenh.) 72, 443-446 (1994).
123. Wylegala E, Dobrowolski D, Tarnawska D, Wroblewska-Czajka E, Jurewicz A. Indications for keratoplasty in District Railway Hospital in Katowice. Klin. Oczna. 107, 646-649 (2005).
124. Poinard C, Tuppin P, Loty B, Delbosc B. The French national waiting list for keratoplasty created in 1999: patient registration, indications, characteristics, and turnover. J. Fr. Ophtalmol. 26, 911-919 (2003).
125. Legeais JM, Parc C, d'Hermies F, Pouliquen Y, Renard G. Nineteen years of penetrating keratoplasty in the Hotel-Dieu Hospital in Paris. Cornea 20, 603-606 (2001).
126. Fasolo A, Frigo AC, Bohm E, et al. The CORTES study: corneal transplant indications and graft survival in an Italian cohort of patients. Cornea 25, 507-515 (2006).
127. Cursiefen C, Kuchle M, Naumann GO. Changing indications for penetrating keratoplasty: histopathology of 1,250 corneal buttons. Cornea 17, 468-470 (1998).
128. Lang GK, Wilk CM, Naumann GO. Changes in the indications status for keratoplasty (Erlangen, 1964-1986). Fortschr. Ophthalmol. 85, 255-258 (1988).
129. Kervick GN, Shepherd WF. Changing indications for penetrating keratoplasty. Ophthalmic. Surg. 21, 227 (1990).
130. Morris RJ, Bates AK. Changing indications for keratoplasty. Eye 3(Pt 4), 455-459 (1989).
131. Al-Yousuf N, Mavrikakis I, Mavrikakis E, Daya SM. Penetrating keratoplasty: indications over a 10 year period. Br. J. Ophthalmol. 88, 998-1001 (2004).
132. Rahman I, Carley F, Hillarby C, Brahma A, Tullo AB. Penetrating keratoplasty: indications, outcomes, and complications. Eye (Lond.) 23(6), 1288-1294 (2009).
133. Calix Netto MJ, Giustina ED, Ramos GZ, Peccini RF, Sobrinho M, de Souza LB. Major indications for corneal penetrating keratoplasty at a reference service in Sao Paulo state (Sorocaba-SP, Brazil). Arq. Bras. Oftalmol. 69, 661-664 (2006).
134. Sano FT, Dantas PE, Silvino WR, et al. Trends in the indications for penetrating keratoplasty. Arq. Bras. Oftalmol. 71, 400-404 (2008).
135. Edwards M, Clover GM, Brookes N, Pendergrast D, Chaulk J, McGhee CN. Indications for corneal transplantation in New Zealand: 1991-1999. Cornea 21, 152-155 (2002)
136. The Australian Corneal Graft Registry. 1990 to 1992 report. Aust. N. Z. J. Ophthalmol. 21, 1-48 (1993).
137. Chen WL, Hu FR, Wang IJ. Changing indications for penetrating keratoplasty in Taiwan from 1987 to 1999. Cornea 20, 141-144 (2001).
138. Xie L, Song Z, Zhao J, Shi W, Wang F. Indications for penetrating keratoplasty in north China. Cornea 26, 1070-1073 (2007). (Pubitemid 47480687)
139. Zhang C, Xu J. Indications for penetrating keratoplasty in East China, 1994-2003. Graefes. Arch. Clin. Exp. Ophthalmol. 243, 1005-1009 (2005).
140. Chan CM, Wong TY, Yeong SM, Lim TH, Tan DT. Penetrating keratoplasty in the Singapore National Eye Centre and donor cornea acquisition in the Singapore Eye Bank. Ann. Acad. Med. Singapore 26, 395-400 (1997).
141. Tan DT, Janardhanan P, Zhou H, et al. Penetrating keratoplasty in Asian eyes: the Singapore Corneal Transplant Study. Ophthalmology 115, 975-982 (2008).
142. Sony P, Sharma N, Sen S, Vajpayee RB. Indications of penetrating keratoplasty in northern India. Cornea 24, 989-991 (2005). (Pubitemid 41688537)
143. Pandrowala H, Bansal A, Vemuganti GK, Rao GN. Frequency, distribution, and outcome of keratoplasty for corneal dystrophies at a tertiary eye care center in South India. Cornea 23, 541-546 (2004).
144. Rao SK, Sudhir RR, Fogla R, Rajagopal R, Sitalakshmi G, Padmanabhan P. Bilateral penetrating keratoplasty-indications, results and review of literature. Int. Ophthalmol. 23, 161-166 (1999).
145. al Faran MF, Tabbara KF. Corneal dystrophies among patients undergoing keratoplasty in Saudi Arabia. Cornea 10; 13-16 (1991).
146. Yahalom C, Mechoulam H, Solomon A, Raiskup FD, Peer J, Frucht-Pery J. Forty years of changing indications in penetrating keratoplasty in Israel. Cornea 24, 256-258 (2005).
147. Frucht-Pery J, Shtibel H, Solomon A, Siganos CS, Yassur Y, Pe'er J. Thirty years of penetrating keratoplasty in Israel. Cornea 16, 16-20 (1997).